Knocking down the expression of Aurora-A gene inhibits cell proliferation and induces G2/M phase arrest in human small cell lung cancer cells

Oncology Reports

Volumn 32, Issue 1, 2014, Pages 243-249

  Lu, Yimin ^a,b   Liu, Yuanhua ^c   Jiang, Jianzhong ^d   Xi, Zhaoqing ^a   Zhong, Ning ^b   Shi, Shunbin ^e   Wang, Jinzhi ^f   Wei, Xiaodong ^g  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b JIANGSU UNIVERSITY   (China)

^c JIANGSU CANCER HOSPITAL   (China)

^d People's Hospital of Yixing City   (China)

^e NANTONG UNIVERSITY   (China)

^f SOOCHOW UNIVERSITY   (China)

^g The 101 Hospital of Chinese PLA   (China)

Author keywords

Aurora A; Lentivirus; RNA interference; Small cell lung cancer cells

Indexed keywords

AURORA A KINASE; LENTIVIRUS VECTOR; PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AURORA KINASE A GENE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; RNA INTERFERENCE; UPREGULATION; ENZYMOLOGY; G2 PHASE CELL CYCLE CHECKPOINT; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; SMALL CELL LUNG CANCER; TUMOR CELL LINE;

APOPTOSIS; AURORA KINASE A; CELL LINE, TUMOR; CELL PROLIFERATION; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; RNA, SMALL INTERFERING; SMALL CELL LUNG CARCINOMA;

EID: 84903139866     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3194     Document Type: Article

References (32)

1. van Meerbeeck JP, Fennell DA and De Ruysscher DK: Small-cell lung cancer. Lancet 378: 1741-1755, 2011.
2. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
3. Lally BE, Urbanic JJ, Blackstock AW, Miller AA and Perry MC: Small cell lung cancer: have we made any progress over the last 25 years? Oncologist 12: 1096-1104, 2007. (Pubitemid 350007021)
4. Oze I, Hotta K, Kiura K, et al: Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results. PLoS One 4: e7835, 2009.
5. Vader G and Lens SM: The Aurora kinase family in cell division and cancer. Biochim Biophys Acta 1786: 60-72, 2008.
6. Nikonova AS, Astsaturov I, Serebriiskii IG, Dunbrack RL Jr and Golemis EA: Aurora A kinase (AURKA) in normal and pathological cell division. Cell Mol Life Sci 70: 661-687, 2013.
7. Katayama H, Brinkley WR and Sen S: The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev 22: 451-464, 2003. (Pubitemid 36791899)
8. Jiang Y, Zhang Y, Lees E and Seghezzi W: AuroraA overexpression overrides the mitotic spindle checkpoint triggered by nocodazole, a microtubule destabilizer. Oncogene 22: 8293-8301, 2003. (Pubitemid 37485522)
9. Anand S, Penrhyn-Lowe S and Venkitaraman AR: AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 3: 51-62, 2003. (Pubitemid 37443890)
10. Zhou H, Kuang J, Zhong L, et al: Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20: 189-193, 1998. (Pubitemid 28455454)
11. Wang X, Zhou YX, Qiao W, et al: Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 25: 7148-7158, 2006. (Pubitemid 44764184)
12. Burnett JC and Rossi JJ: RNA-based therapeutics: current progress and future prospects. Chem Biol 19: 60-71, 2012.
13. Watts JK and Corey DR: Silencing disease genes in the laboratory and the clinic. J Pathol 226: 365-379, 2012.
14. Castanotto D and Rossi JJ: The promises and pitfalls of RNA-interference-based therapeutics. Nature 457: 426-433, 2009.
15. Ketting RF: The many faces of RNAi. Dev Cell 20: 148-161, 2011.
16. Stovold R, Blackhall F, Meredith S, Hou J, Dive C and White A: Biomarkers for small cell lung cancer: neuroendocrine, epithelial and circulating tumour cells. Lung Cancer 76: 263-268, 2012.
17. Bischoff JR, Anderson L, Zhu Y, et al: A homologue of Drosophila aurora kinase is oncogenic and amplified in human cancers. EMBO J 17: 3052-3065, 1998. (Pubitemid 28254378)
18. Reiter R, Gais P, Jütting U, et al: Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin Cancer Res 12: 5136-5141, 2006. (Pubitemid 44453341)
19. Lassus H, Staff S, Leminen A, Isola J and Butzow R: Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma. Gynecol Oncol 120: 11-17, 2011.
20. Stein EV, Price DK and Figg WD: shRNA technology: investigating Ras-dependent cancer. Cancer Biol Ther 8: 1798-1799, 2009.
21. Luo J, Emanuele MJ, Li D, et al: A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 137: 835-848, 2009.
22. Brummelkamp TR, Bernards R and Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553, 2002. (Pubitemid 34408678)
23. Wang X, Dong L, Xie J, Tong T and Zhan Q: Stable knockdown of Aurora-A by vector-based RNA interference in human esophageal squamous cell carcinoma cell line inhibits tumor cell proliferation, invasion and enhances apoptosis. Cancer Biol Ther 8: 1852-1859, 2009.
24. Wang X, Lu N, Niu B, Chen X, Xie J and Cheng N: Overexpression of Aurora-A enhances invasion and matrix metalloproteinase-2 expression in esophageal squamous cell carcinoma cells. Mol Cancer Res 10: 588-596, 2012.
25. Yang G, Chang B, Yang F, et al: Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res 16: 3171-3181, 2010.
26. Satyanarayana A and Kaldis P: Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 28: 2925-2939, 2009.
27. Riabowol K, Draetta G, Brizuela L, Vandre D and Beach D: The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell 57: 393-401, 1989. (Pubitemid 19126273)
28. Dutertre S, Cazales M, Quaranta M, et al: Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition. J Cell Sci 117: 2523-2531, 2004. (Pubitemid 38877848)
29. Kelly PN and Strasser A: The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ 18: 1414-1424, 2011.
30. Qi F, Inagaki Y, Gao B, et al: Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways. Cancer Sci 102: 951-958, 2011.
31. Oltersdorf T, Elmore SW, Shoemaker AR, et al: An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435: 677-681, 2005. (Pubitemid 40825512)
32. Gu X, Yao Y, Cheng R, et al: Plasminogen K5 activates mitochondrial apoptosis pathway in endothelial cells by regulating Bak and Bcl-xL subcellular distribution. Apoptosis 16: 846-855, 2011.